Welcome to LookChem.com Sign In|Join Free

CAS

  • or

916213-60-0

Post Buying Request

916213-60-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

916213-60-0 Usage

Description

4-bromo-3-hydroxybenzonitrile is a chemical compound that features a benzene ring with a hydroxyl group and a nitrile group attached to it, along with a bromine atom at the 4th position. It is a white to off-white solid and is widely recognized for its applications in organic synthesis and pharmaceutical research.

Uses

Used in Pharmaceutical Research:
4-bromo-3-hydroxybenzonitrile is utilized as a key intermediate in the production of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
4-bromo-3-hydroxybenzonitrile serves as a versatile building block in the synthesis of other organic compounds, facilitating the creation of a broad range of chemical products.
Used in Agrochemical Production:
4-bromo-3-hydroxybenzonitrile is employed as an intermediate in the manufacturing of agrochemicals, playing a crucial role in the development of agricultural products to enhance crop protection and yield.
Used in Fine Chemicals Manufacturing:
It is also used in the production of other fine chemicals, indicating its importance in various specialized chemical industries.
Used as a Reagent in Chemical Reactions:
4-bromo-3-hydroxybenzonitrile is often used as a reagent, highlighting its utility in facilitating specific chemical reactions and processes.

Check Digit Verification of cas no

The CAS Registry Mumber 916213-60-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,2,1 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 916213-60:
(8*9)+(7*1)+(6*6)+(5*2)+(4*1)+(3*3)+(2*6)+(1*0)=150
150 % 10 = 0
So 916213-60-0 is a valid CAS Registry Number.

916213-60-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-bromo-3-hydroxybenzonitrile

1.2 Other means of identification

Product number -
Other names 2-BROMO-5-CYANOPHENOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:916213-60-0 SDS

916213-60-0Downstream Products

916213-60-0Relevant articles and documents

Identification of 4-(4-nitro-2-phenethoxyphenyl)pyridine as a promising new lead for discovering inhibitors of both human and rat 11β-Hydroxylase

Hu, Qingzhong,Kunde, Jessica,Hanke, Nina,Hartmann, Rolf W.

supporting information, p. 139 - 150 (2015/04/22)

The inhibition of 11β-hydroxylase is a promising strategy for the treatment of Cushing's syndrome, in particular for the recurrent and subclinical cases. To achieve proof of concept in rats, efforts were paid to identify novel lead compounds inhibiting both human and rat CYP11B1. Modifications on a potent promiscuous inhibitor of hCYP11B1, hCYP11B2 and hCYP19 (compound IV) that exhibited moderate rCYP11B1 inhibition led to compound 8 as a new promising lead compound. Significant improvements compared to starting point IV were achieved regarding inhibitory potency against both human and rat CYP11B1 (IC50 values of 2 and 163 nM, respectively) as well as selectivity over hCYP19 (IC50 Combining double low line 1900 nM). Accordingly, compound 8 was around 7-and 28-fold more potent than metyrapone regarding the inhibition of human and rat CYP11B1 and exhibited a comparable selectivity over hCYP11B2 (SF of 3.5 vs 4.9). With further optimizations on this new lead compound 8, drug candidates with satisfying profiles are expected to be discovered.

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

-

Page/Page column 263, (2008/06/13)

The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 916213-60-0